These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 12194996)

  • 1. Epstein-Barr virus in gastric adenocarcinomas: association with ethnicity and CDKN2A promoter methylation.
    Vo QN; Geradts J; Gulley ML; Boudreau DA; Bravo JC; Schneider BG
    J Clin Pathol; 2002 Sep; 55(9):669-75. PubMed ID: 12194996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helicobacter pylori and EBV in gastric carcinomas: methylation status and microsatellite instability.
    Ferrasi AC; Pinheiro NA; Rabenhorst SH; Caballero OL; Rodrigues MA; de Carvalho F; Leite CV; Ferreira MV; Barros MA; Pardini MI
    World J Gastroenterol; 2010 Jan; 16(3):312-9. PubMed ID: 20082476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EBV-infection in cardiac and non-cardiac gastric adenocarcinomas is associated with promoter methylation of p16, p14 and APC, but not hMLH1.
    Geddert H; Zur Hausen A; Gabbert HE; Sarbia M
    Anal Cell Pathol (Amst); 2010; 33(3):143-9. PubMed ID: 20978327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of p16/CDKN2A tumor suppressor protein in gastric adenocarcinoma is associated with Epstein-Barr virus and anatomic location in the body of the stomach.
    Schneider BG; Gulley ML; Eagan P; Bravo JC; Mera R; Geradts J
    Hum Pathol; 2000 Jan; 31(1):45-50. PubMed ID: 10665912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDKN2A promoter methylation in gastric adenocarcinomas: clinical variables.
    Vo QN; Geradts J; Boudreau DA; Bravo JC; Schneider BG
    Hum Pathol; 2002 Dec; 33(12):1200-4. PubMed ID: 12514789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EBV-infection in cardiac and non-cardiac gastric adenocarcinomas is associated with promoter methylation of p16, p14 and APC, but not hMLH1.
    Geddert H; zur Hausen A; Gabbert HE; Sarbia M
    Cell Oncol (Dordr); 2011 Jun; 34(3):209-14. PubMed ID: 21538028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced expression and promoter methylation of p16 gene in Epstein-Barr virus-associated gastric carcinoma.
    Osawa T; Chong JM; Sudo M; Sakuma K; Uozaki H; Shibahara J; Nagai H; Funata N; Fukayama M
    Jpn J Cancer Res; 2002 Nov; 93(11):1195-200. PubMed ID: 12460459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P16 protein abnormality in Epstein-Barr virus-associated gastric carcinomas.
    Ojima H; Saito K; Yamauchi H; Yamaki E; Idetu A; Hosouchi Y; Nishida Y; Tukada K; Kato H; Kuwano H
    Anticancer Res; 2006; 26(2A):933-7. PubMed ID: 16619489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant gene promoter methylation of p16, FHIT, CRBP1, WWOX, and DLC-1 in Epstein-Barr virus-associated gastric carcinomas.
    He D; Zhang YW; Zhang NN; Zhou L; Chen JN; Jiang Y; Shao CK
    Med Oncol; 2015 Apr; 32(4):92. PubMed ID: 25720522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic implication of molecular subtypes and response to neoadjuvant chemotherapy in 760 gastric carcinomas: role of Epstein-Barr virus infection and high- and low-microsatellite instability.
    Kohlruss M; Grosser B; Krenauer M; Slotta-Huspenina J; Jesinghaus M; Blank S; Novotny A; Reiche M; Schmidt T; Ismani L; Hapfelmeier A; Mathias D; Meyer P; Gaida MM; Bauer L; Ott K; Weichert W; Keller G
    J Pathol Clin Res; 2019 Oct; 5(4):227-239. PubMed ID: 31206244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter hypermethylation of E-cadherin and its abnormal expression in Epstein-Barr virus-associated gastric carcinoma.
    Sudo M; Chong JM; Sakuma K; Ushiku T; Uozaki H; Nagai H; Funata N; Matsumoto Y; Fukayama M
    Int J Cancer; 2004 Mar; 109(2):194-9. PubMed ID: 14750169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing and CpG island methylation of GSTP1 is rare in ordinary gastric carcinomas but common in Epstein-Barr virus-associated gastric carcinomas.
    Kim J; Lee HS; Bae SI; Lee YM; Kim WH
    Anticancer Res; 2005; 25(6B):4013-9. PubMed ID: 16309193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p73 gene promoter methylation in Epstein-Barr virus-associated gastric carcinoma.
    Ushiku T; Chong JM; Uozaki H; Hino R; Chang MS; Sudo M; Rani BR; Sakuma K; Nagai H; Fukayama M
    Int J Cancer; 2007 Jan; 120(1):60-6. PubMed ID: 17058198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma.
    Kang GH; Lee S; Kim WH; Lee HW; Kim JC; Rhyu MG; Ro JY
    Am J Pathol; 2002 Mar; 160(3):787-94. PubMed ID: 11891177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus and gastric carcinoma.
    Fukayama M
    Pathol Int; 2010 May; 60(5):337-50. PubMed ID: 20518883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classification of Epstein-Barr virus-positive gastric cancers by definition of DNA methylation epigenotypes.
    Matsusaka K; Kaneda A; Nagae G; Ushiku T; Kikuchi Y; Hino R; Uozaki H; Seto Y; Takada K; Aburatani H; Fukayama M
    Cancer Res; 2011 Dec; 71(23):7187-97. PubMed ID: 21990320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDKN2A promoter methylation is related to the tumor location and histological subtype and associated with Helicobacter pylori flaA(+) strains in gastric adenocarcinomas.
    Alves MK; Lima VP; Ferrasi AC; Rodrigues MA; De Moura Campos Pardini MI; Rabenhorst SH
    APMIS; 2010 Apr; 118(4):297-307. PubMed ID: 20402675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of Epstein--Barr virus infection as detected by messenger RNA for EBNA 1 in histologically proven gastric adenocarcinoma in patients presenting to a tertiary care center in South India.
    Rymbai ML; Ramalingam VV; Samarasan I; Chandran BS; Mathew G; Jerobin J; Abraham AM; Sachithanandham J; Kannangai R
    Indian J Med Microbiol; 2015; 33(3):369-73. PubMed ID: 26068337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of p16/CDKN2A protein in Epstein-Barr virus-associated gastric carcinoma.
    Koriyama C; Kitajima S; Nomoto M; Sueyoshi K; Itoh T; Eizuru Y; Yonezawa S; Akiba S
    Oncology; 2004; 67(1):81-7. PubMed ID: 15459500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Epstein-Barr virus infection and p16(INK4a) overexpression in gastric adenocarcinoma].
    Wang P; Zhang Q; Yang JF; Cheng ZN; Zhang K; Yu DH
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Aug; 22(4):244-6. PubMed ID: 19105332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.